Volume 13, Issue 2, Pages (February 2011)

Slides:



Advertisements
Similar presentations
Volume 16, Issue 6, Pages (August 2016)
Advertisements

Volume 11, Issue 4, Pages (April 2003)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 36, Issue 5, Pages (December 2009)
Volume 33, Issue 2, Pages (January 2009)
90K Glycoprotein Promotes Degradation of Mutant β-Catenin Lacking the ISGylation or Phosphorylation Sites in the N-terminus  So-Yeon Park, Somy Yoon,
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Phosphorylation of Cdc20 by Bub1 Provides a Catalytic Mechanism for APC/C Inhibition by the Spindle Checkpoint  Zhanyun Tang, Hongjun Shu, Dilhan Oncel,
Volume 57, Issue 3, Pages (February 2015)
Volume 134, Issue 2, Pages (July 2008)
Volume 110, Issue 2, Pages (July 2002)
Volume 87, Issue 7, Pages (December 1996)
Volume 36, Issue 2, Pages (October 2009)
Volume 8, Issue 6, Pages (December 2008)
Volume 18, Issue 17, Pages (September 2008)
Volume 22, Issue 5, Pages (May 2012)
Volume 64, Issue 3, Pages (November 2016)
p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway
Volume 13, Issue 2, Pages (February 2011)
Volume 52, Issue 4, Pages (November 2013)
Eun-Joo Kim, Jeong-Hoon Kho, Moo-Rim Kang, Soo-Jong Um  Molecular Cell 
Volume 45, Issue 5, Pages (March 2012)
Volume 137, Issue 5, Pages (May 2009)
Volume 68, Issue 2, Pages e6 (October 2017)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 10, Issue 3, Pages (September 2009)
Stefanie S. Schalm, Diane C. Fingar, David M. Sabatini, John Blenis 
Volume 29, Issue 3, Pages (February 2008)
Volume 54, Issue 3, Pages (May 2014)
Calnexin Controls the STAT3-Mediated Transcriptional Response to EGF
Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies  O.Jameel Shah,
Volume 93, Issue 5, Pages (May 1998)
Volume 18, Issue 5, Pages (January 2017)
Sestrins Inhibit mTORC1 Kinase Activation through the GATOR Complex
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 46, Issue 6, Pages (June 2012)
Volume 34, Issue 4, Pages (May 2009)
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Volume 47, Issue 1, Pages (July 2012)
Volume 45, Issue 6, Pages (March 2012)
Volume 17, Issue 2, Pages (January 2007)
Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase  Yosuke Yoneyama, Tomomi Inamitsu, Kazuhiro Chida, Shun-Ichiro.
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 8, Issue 5, Pages (November 2008)
Glutaminolysis Activates Rag-mTORC1 Signaling
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Volume 58, Issue 5, Pages (June 2015)
Volume 14, Issue 14, Pages (July 2004)
Volume 17, Issue 8, Pages (April 2007)
Volume 19, Issue 8, Pages (April 2009)
Disruption of the Rag-Ragulator Complex by c17orf59 Inhibits mTORC1
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Takashi Hayashi, Gareth M. Thomas, Richard L. Huganir  Neuron 
Yvonne Ng, Georg Ramm, Jamie A. Lopez, David E. James  Cell Metabolism 
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
Volume 34, Issue 6, Pages (June 2009)
Fig. 6 IPMK-TRAF6 binding is negatively regulated by IRAK1.
Growth Factor-Dependent Trafficking of Cerebellar NMDA Receptors via Protein Kinase B/Akt Phosphorylation of NR2C  Bo-Shiun Chen, Katherine W. Roche 
Volume 68, Issue 3, Pages e5 (November 2017)
In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets  Weiguo Zhai, Hyunkyung Jeong, Libin.
Volume 9, Issue 1, Pages (January 2002)
Volume 3, Issue 4, Pages (April 1999)
Phosphorylation and Functional Inactivation of TSC2 by Erk
Lysosomal Rag-ulation of mTOR Complex 1 Activity
Volume 57, Issue 2, Pages (January 2015)
Volume 11, Issue 5, Pages (May 2010)
Volume 31, Issue 5, Pages (September 2008)
Volume 58, Issue 3, Pages (May 2015)
Presentation transcript:

Volume 13, Issue 2, Pages 215-221 (February 2011) Amino Acid Signaling to mTOR Mediated by Inositol Polyphosphate Multikinase  Seyun Kim, Sangwon F. Kim, David Maag, Micah J. Maxwell, Adam C. Resnick, Krishna R. Juluri, Anutosh Chakraborty, Michael A. Koldobskiy, Seung Hun Cha, Roxanne Barrow, Adele M. Snowman, Solomon H. Snyder  Cell Metabolism  Volume 13, Issue 2, Pages 215-221 (February 2011) DOI: 10.1016/j.cmet.2011.01.007 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 IPMK Depletion Diminishes Amino Acid Signaling and mTOR-Raptor Interactions (A) Wild-type (WT) and IPMK-depleted (KO) MEFs were grown in 10% serum, nutrient-rich medium (control), deprived of serum and amino acids (leucine, arginine, or total amino acids) for 1 hr. Cells were stimulated by leucine (400 μM), arginine (400 μM), or total amino acids mixture (1×) for 10 min. (B) In vitro mTORC1 activity assay from MEFs. (C) MEFs were deprived of leucine for 24 hr and stimulated with leucine (400 μM) for 12 hr. Cell size was analyzed from at least 8000 cells per trial (n = 3). Bars represent mean ± SEM. (D) IPMK-depleted MEFs stably expressing wild-type or the catalytically inactive, mutant IPMK (K129A) were analyzed as in (A). (E) mTOR, raptor, and rictor immunoprecipitates were isolated in the presence of DSP, and the amount of indicated mTORC subunits was analyzed. Bars in (A), (B), and (E) represent mean ± SD (n = 4). ∗∗p < 0.01. Cell Metabolism 2011 13, 215-221DOI: (10.1016/j.cmet.2011.01.007) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 IPMK Is an mTOR-Associated Protein (A) GST or GST-hIPMK was expressed in HEK293T cells, followed by pull-down and immunoblotting for endogenous mTOR. (B) GFP or GFP-hIPMK was cotransfected in HEK293T cells with myc-mTOR, and immunoprecipitates were analyzed by immunoblotting. (C) Lysates from IPMK-depleted MEFs stably expressing wild-type mouse IPMK were immunoprecipitated with indicated antibodies. (D) The unique sequence found in mammalian IPMK is aligned and indicated with a red box. Yeast IPMK-specific, polyaspartates sequence (Poly-D; green), and two conserved domains for inositol binding (blue) and kinase activity (yellow) are shown. IPMK fragments used for binding studies are shown in the schematic with the number of the amino acid sequence. (E) HA-mTOR or HA-raptor was cotransfected in HEK293T cells with wild-type or 1–60 deleted human IPMK (Δ1-60) constructs, followed by immunoprecipitation with HA-antibodies and immunoblotting. (F) Myc-wild-type mTOR, 1–1482 (N-ter) fragment, or 1328–2549 (C-ter) fragment was cotransfected in HEK293T cells with GFP or GFP-hIPMK-1-60, and myc-immunoprecipitates were analyzed by immunoblotting. (G) GST or GST-hIPMK-1-60 was incubated with mTOR purified from HEK293T cells. (H) GST or GST-hIPMK was cotransfected in HEK293T cells with myc-raptor, followed by pull-down and immunoblotting. Cell Metabolism 2011 13, 215-221DOI: (10.1016/j.cmet.2011.01.007) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Human IPMK-1-60 Peptide Interferes with mTOR-Raptor Binding and Amino Acid Signaling (A) HEK293T cells transfected with GFP or GFP-hIPMK-1-60 were deprived of serum and leucine for 1 hr and stimulated with leucine for 10 min. mTORC1 and mTORC2 were isolated in the presence of DSP, and the amount of mTOR was analyzed. (B) S6K phosphorylation and protein expression were analyzed by immunoblotting. (C) The amount of myc-raptor bound in mTOR pull-down and in vitro mTORC1 activity were analyzed. mTOR immunopurified from leucine-treated HEK293T cells and myc-raptor (100 nM) were coincubated with GST or GST-hIPMK-1-60 (200 nM). Bars represent mean ± SD (n = 3 in A and C, n = 4 in B). ∗p < 0.05; ∗∗p < 0.01. Cell Metabolism 2011 13, 215-221DOI: (10.1016/j.cmet.2011.01.007) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 The Amino Terminus of IPMK Is Involved in mTOR-Raptor Binding and Amino Acid Signaling (A) In the presence of DSP, raptor immunoprecipitates were isolated from IPMK-depleted MEFs stably expressing vector (Vec), wild-type (WT), or the deletion mutant IPMK (Δ1-31) followed by immunoblotting. (B) S6K phosphorylation and protein expression were analyzed by immunoblotting. Bars represent mean ± SD (n = 3). ∗p < 0.05; ∗∗p < 0.01. (C) A model depicting regulation of mTORC1 signaling by IPMK in response to amino acids. In the absence of amino acids, IPMK binds with high affinity to mTORC1, the N-terminal portion of IPMK interacting with mTOR and the C terminus with raptor. Amino acid stimulation transforms the complex into a low-affinity state, whereupon the complex translocates to the lysosomal surface. The active Rag/Regulator complex associates with raptor, and active GTP-Rheb binds to mTOR, thereby enhancing mTOR activity (Sancak et al., 2010). In the absence of IPMK the mTOR-raptor complex dissociates, at least partially. Amino acid treatment still enhances raptor binding to the active Rag/Regulator complex, but GTP-Rheb fails to bind/activate mTOR. Cell Metabolism 2011 13, 215-221DOI: (10.1016/j.cmet.2011.01.007) Copyright © 2011 Elsevier Inc. Terms and Conditions